Benefits and harms of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2‐I) and renin–angiotensin–aldosterone system inhibitors (RAAS‐I) versus SGLT2‐Is alone in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Benefits and harms of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2‐I) and renin–angiotensin–aldosterone system inhibitors (RAAS‐I) versus SGLT2‐Is alone in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Published:2021-10-12 Issue:1 Volume:5 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrino Diabet & Metabol

Author:

Seidu Samuel¹^ORCID,Kunutsor Setor K²³^ORCID,Topsever Pinar⁴,Khunti Kamlesh¹

Affiliation:

1. Diabetes Research Centre University of LeicesterLeicester General Hospital Leicester UK

2. National Institute for Health Research Bristol Biomedical Research CentreUniversity Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol Bristol UK

3. Translational Health Sciences Bristol Medical School Learning & Research Building (Level 1) University of BristolSouthmead Hospital Bristol UK

4. Department of Family Medicine Acibadem Mehmet Ali Aydinlar University School of MedicineKerem Aydinlar Campus Atasehir Turkey

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.303

Reference47 articles.

1. Type 2 diabetes

2. The Economic Costs of Type 2 Diabetes: A Global Systematic Review

3. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

4. Screening for Kidney Disease in Adults With Diabetes

5. WHO Health Topics.Diabetes.https://www.who.int/health‐topics/diabetes#tab = tab_1. Accessed on 29 April 2021.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

2. Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity;Frontiers in Pharmacology;2024-07-30

3. Hypertension and Heart Failure: From Pathophysiology to Treatment;International Journal of Molecular Sciences;2024-06-17

4. Applications of SGLT2 inhibitors beyond glycaemic control;Nature Reviews Nephrology;2024-04-26

5. Combination therapy for kidney disease in people with diabetes mellitus;Nature Reviews Nephrology;2024-04-03